Ovarian Cancer Stem Cells


According to the cancer stem cell (CSC) paradigm, cancer cells that have not undergone differentiation and are capable of self-renewal and tumor-initiating activity are what sustain and feed the growth and spread of tumors. Ovarian cancer is regarded as a model case of CSC-driven illness, which is supported by its biological characteristics and clinical evolution. Indeed, ovarian cancer stem cells (OCSC) would explain not only the initial tumor growth, the peritoneal spread, and also the relapse, but also the emergence of chemo resistance, having significant implications for the therapy of this fatal disease.


 


 



 


    Related Conference of Ovarian Cancer Stem Cells

    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany
    October 14-15, 2024

    4th International Conference on Analytical Chemistry

    Barcelona, Spain
    October 31-01, 2024

    14th International Chemistry Congress

    Amsterdam, Netherlands
    November 13-14, 2024

    5th World Expo on Biopolymers and Bioplastics

    Dubai, UAE
    November 27-28, 2024

    14th World Congress on Analytical & Bioanalytical Techniques

    Amsterdam, Netherlands
    November 28-29, 2024

    20th European Organic Chemistry Congress

    Aix-en-Provence, France
    December 12-13, 2024

    23rd World Congress on Nutrition and Food Chemistry

    Rome, Italy
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands
    January 27-28, 2025

    25th World Congress on Medicinal Chemistry and Drug Design

    Bangkok, Thailand
    March 13-14, 2025

    2nd International Conference on Drug Discovery and Development

    Prague, Czech Republic
    April 07-08, 2025

    15th World Congress on Chemistry

    Vancouver, Canada
    June 26-27, 2025

    14th World Congress on Chromatography

    Aix-en-Provence, France

    Ovarian Cancer Stem Cells Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in